Safety And Effectiveness Of NaviFUS System With Bevacizumab In Recurrent Glioblastoma

NCT07274787 · clinicaltrials.gov ↗

NA

Phase

NOT_YET_RECRUITING

Status

10

Enrollment

OTHER

Sponsor class

Conditions

GBM

Interventions

DEVICE: NaviFUS System
DRUG: Lumason
DRUG: Bevacizumab

Sponsor

University of Cincinnati

Collaborators

[object Object]